Kolexia
Krempf Michel
Médecine interne
Hôpital Laennec
Saint-Herblain, France
245 Activités
602 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Hypercholestérolémie Hyperlipoprotéinémie de type II Obésité Diabète de type 2 Diabète Dyslipidémies Hypertriglycéridémie Athérosclérose Insulinorésistance

Industries

Servier
16 collaboration(s)
Dernière en 2023
AstraZeneca
10 collaboration(s)
Dernière en 2023
Organon BioSciences
5 collaboration(s)
Dernière en 2022
Sanofi
5 collaboration(s)
Dernière en 2023

Dernières activités

Integrated omics approach for the identification of HDL structure-function relationships in PCSK9-related familial hypercholesterolemia.
Journal of clinical lipidology   27 juillet 2023
Hepatic deletion of serine palmitoyl transferase 2 impairs ceramide/sphingomyelin balance, bile acids homeostasis and leads to liver damage in mice.
Biochimica et biophysica acta. Molecular and cell biology of lipids   22 mai 2023
Effect of omega-3 fatty acid ethyl esters on postprandial arterial elasticity in patients with familial hypercholesterolemia.
Clinical nutrition ESPEN   21 mars 2023
Evaluation of hypercholesterolemia management in at-risk patients by cardiologists in France: a case vignette-based study.
Journal of comparative effectiveness research   08 mars 2023
Description des pratiques de l’insulinothérapie basale dans le diabète de type 2 en médecine générale en France : l’étude PRACTISULINE®
Médecine des Maladies Métaboliques   20 août 2022
Postprandial apolipoprotein(a) metabolism in familial hypercholesterolaemia: Therapeutic effect of omega-3 fatty acid supplementation
Atherosclerosis   01 août 2022
Untargeted lipidomic analysis of plasma from obese women submitted to combined physical exercise.
Scientific reports   07 juillet 2022
Effect of Omega-3 Fatty Acid Supplementation on the Postprandial Metabolism of Apolipoprotein(a) in Familial Hypercholesterolemia.
Journal of atherosclerosis and thrombosis   08 juin 2022
MK0653C in High Cardiovascular Risk Patients With High Cholesterol (Switch Study)(MK-0653C-162): A Randomized, Double-Blind, Active-Controlled, Multicenter Study of Patients With Primary Hypercholesterolemia and High Cardiovascular Risk Who Are Not Adequately Controlled With Atorvastatin 10 mg: A Comparison of the Efficacy and Safety of Switching to Coadministration Ezetimibe and Atorvastatin Versus Doubling the Dose of Atorvastatin or Switching to Rosuvastatin
Essai Clinique (Organon BioSciences)   07 février 2022
Bariatric Surgery Improves the Atherogenic Profile of Circulating Methylarginines in Obese Patients: Results from a Pilot Study.
Metabolites   04 novembre 2021